Synthetic Genomics
Doug Miller has a extensive background in finance and consulting, with experience as Chief Financial Officer at Viridos, VP and Corporate Controller at Halozyme Therapeutics, Inc., and VP Finance - Medical Systems Segment CFO at CareFusion. Prior to their corporate roles, Doug worked as a Partner at PricewaterhouseCoopers focusing on audit, capital markets, and transaction services. Doug holds a BS in Government from Wesleyan University and an MBA from Questrom School of Business, Boston University.
This person is not in any offices